Celgene reports positive survival data from multiple myeloma study; EC approves Bayer's Xarelto; Atox reports positive data, plans to raise funds;

Conversations on Twitter :

 @FierceBiotech: GSK's new Promacta approval triggers a spike for Ligand shares. News | Follow @FierceBiotech

 @JohnCFierce: Celgene, Sanofi execs in (another) biopharma insider trading case. Is it that hard for insiders to get away with this? Story | Follow @JohnCFierce

 @RyanMFierce: Rare disease R&D and academic/pharma tie-up trends have melded in Shire's new alliance with Boston Children's. More | Follow @RyanMFierce

> Celgene ($CELG) reports that its experimental cancer drug pomalidomide along with a low dose of a standard therapy significantly extended the lives of late-stage multiple myeloma patients who had failed an average of 5 therapies. Story

> Bayer's oral anticoagulant Xarelto (rivaroxaban) has been approved by the European Commission for the treatment of pulmonary embolism and the prevention of recurrent deep vein thrombosis and PE in adults. Release

> Globes reports that Israel's Atox Bio is out raising funds as it reports positive data from a Phase IIa study of AB103 for necrotizing soft tissue infections. Story

> Eli Lilly ($LLY) has moved up to the #51 slot on the S&P 500, taking Boeing's place on the list. Story

Pharma News

@FiercePharma: New special report for a short week: The world's 20 best-selling generic drugs. Not just the usual suspects. Special Report | Follow @FiercePharma

> Bayer says trumping Reckitt's $1.4B Schiff bid is too rich. Story

> Overnight success proves elusive for oral MS drugs. News

> Sanofi, Celgene execs charged in insider trading ring. Article

Medical Device News

 @FierceMedDev: Spread the word - we're highlighting some of the top M&A targets in devices and diagnostics. Special Report | Follow @FierceMedDev

 @MarkHFierce: Could the device tax lead to supply problems? Item | Follow @MarkHFierce

 @DamianFierce: The SEC says employees of Stryker, Celgene and Sanofi carried on a complex insider trading scam. Report | Follow @DamianFierce

> Push to create pediatric medical devices brings Cincinnati Children's to Israel. Story

> Medtronic sees profit slip despite uptick in revenue. News

And Finally….Investigators at Wake Forest Baptist have been studying whether musical notes can balance brain waves in a new approach to treating insomnia. The technology is being advanced by Brain State Technologies in Scottsdale, AZ. Release


Suggested Articles

Across its 15-year history, Omega Funds has a hand in a clutch of high-profile biotechs such as Editas Medicine and Juno Therapeutics.

After Novartis’ near $10 billion buyout of The Medicines Company, many thought cardiovascular therapies were hot again.

Mutations in RIPK1 can cause uncontrolled cell death and inflammation, researchers discovered by studying families with an autoimmune disorder.